Funds & Grants

The competition International Joint Initiative for Research Harnessing Disruptive Technologies to Address Global Challenges has now been launched starting with a Notice of intent to apply (NOI).

After working with countless grant supported projects, one thing is clear: Grants aren't won on technology alone! What breaks most proposals: Partners chosen for availability, not strategy Big names" without real evaluative weight Roles that don't match past winning patterns No level of technical brilliance fixes that. The real challenge isn't the paperwork: Who actually wins in this topic? New innovation intelligence tools now make it possible to: ->See who has won before and how ->Understand proven consortium patterns ->Design structure first, then build the proposal That shift from intuition to intelligence is core to how we think about Group4Grant."

The International Human Frontier Science Programme (HFSP), a non-profit organisation supporting frontier research in the life sciences, backed by 15 countries and the European Commission, is launching a call for its 2027 research grants of up to $500,000 per year. Opening in late January, the programme seeks to deepen understanding of the mechanisms that govern living systems, spanning genes and molecules, organisms and cognition, as well as populations and ecosystems. Applicants may apply to either: the Research Grants – Programme, open to teams at any career stage, or the Research Grants – Early Career, designed for scientists in the early years of their… Discover the latest in research funding every Tuesday with Funding Newswire. Dive into detailed articles with our monthly or yearly subscriptions or start with a free trial NOTE: if you're a part of one of our Network member organisations, you get free access by signing up with your institutional email.

EIC Advanced Innovation Challenges aim to support high-risk, demand-driven deep tech innovation with transformative potential especially in areas where there is extensive research but lack of commercial uptake.

The agency remains committed to supporting rigorous, evidence-based research that advances the health of all Americans. The Massachusetts Attorney General's Office, one of the plaintiffs, said Tuesday that 5,000 grants nationally were included in the agreement that grew out of the litigation it filed with other state AGs, one of two suits challenging grant delays and terminations being heard by a federal judge in Boston. The uncertainty led to projects on Alzheimer's disease being delayed, and to the flagship UMass Amherst campus reducing the size of its graduate school cohort this fall from 997 to 712 doctoral students and taking away financial support from many of those who were admitted. "The problem is the review is only part of the process, and the administration has been asserting its ability to make decisions however it wants to make decisions. So I'm not sure there's anything that precludes NIH from reviewing all of the applications that are subject to the lawsuit, and then summarily deciding that they're not going to fund any of them because they're no longer aligned with agency priorities," said Jeremy Berg, who previously led one of the NIH's institutes and submitted a declaration in the federal court case."

The National Institutes of Health (NIH) has agreed in lawsuit settlements with potential grantees and state attorneys general to review applications that were frozen, denied, or withdrawn earlier this year because of directives by President Donald Trump's administration targeting research related to topics such as transgender health and diversity, equity, and inclusion (DEI). The agency will evaluate each application in good faith" using its standard processes, stated a joint stipulation filed yesterday with plaintiff scientists and several groups representing them. (There is a similar settlement with the state attorneys general.) In return, the plaintiffs in both cases agreed to drop their remaining claims."

Ready to scale, connect, and transform? Dive into these EU funding opportunities supporting innovation, growth, and collaboration across Europe 👇 🔬 Scaling up deep tech ecosystems ➡️ Supporting deep tech innovations with breakthrough potential linked to pan-European research infrastructures 📅 Deadline: 20 January 🔗https://lnkd.in/earET-Vq 🤖 Consolidation of the European Digital Innovation Hubs Network (reinforced AI focus) ➡️ Strengthen EDIHs' role in supporting SMEs and the public sector with digital transformation, with a strong focus on AI development, training, deployment and uptake 📅 Deadline: 3 March 🔗https://lnkd.in/ehuMndPv 🚀 European Startup and Scaleup Hubs Pilot (HORIZON‑EIE‑2026‑02‑CONNECT‑01) ➡️ Support the growth and interconnection of leading startup and scaleup hubs across Europe to strengthen networks and amplify innovation 📅 Deadline: 10 March 🔗https://lnkd.in/eqWGN-7D #ECCP #EUClusters

Since 2014, Horizon Europe and Horizon 2020 have invested more than €3.9 billion in nearly 1,900 health biotechnology research projects, strengthening Europe's capacity in stem cells, gene and cell therapies, vaccines, nanomedicines and more. 🖨️ Human bioprinting From 4D-printed surgical treatments to bio-printed corneas and alternatives to donor organs, Europe is also driving breakthroughs in tissue and organ bioprinting with €389+ million supporting 180 projects. These investments contribute directly to the EU's broader ambition to build a competitive, resilient and future-ready biotechnology ecosystem under the European Life Sciences Strategy. And this week's publication of the Commission's Biotech Act reinforces this ambition by creating clearer pathways for innovation, strengthening Europe's competitiveness, and supporting the scale-up of high-value biomanufacturing across the Union.

The 2026 Work Programme establishes two calls under the Industry pillar, across two destinations: HORIZON-CL4-2026-01 (€ 319 million, 15 topics, single stage) and HORIZON-CL4-2026-02-two-stage (€ 98 million, 3 topics, two-stage). Two other calls, HORIZON-RAISE-2026-01 (€ 27.8million, 2 topics) and HORIZON-CID-2026-01 (€ 125 million, 1 topic) complete the funding opportunities.

The National Agency for Breakthrough Innovation would be Europe's latest new invention body A major report on the future of Dutch R&D has recommended setting up a new innovation agency, following the establishment of similar bodies in the UK and Germany. Wennink argues that the Darpa model yields significantly more disruptive breakthroughs than traditional grant models." He wants NABI to be independent of the government, with a mission to develop "groundbreaking technologies" in four strategic areas of R&D: digitalisation and artificial intelligence, security and resilience, energy and climate technology, and life sciences and biotechnology. "Just like in Germany [when it established Sprind], it will require dedicated legislation which will have to be approved by Parliament, notably to let the agency operate in a fast and flexible way and avoid that it will be stifled by red tape and all kinds of control and supervisory bodies and even worst, by accountants running the show ," he said. The Wennink report comes just as the Netherlands is winding down a multi-billion euro National Growth Fund, which means "a gap has emerged in the stimulation of innovation," said Ruben Puylaert, a spokesman for Universities of the Netherlands, an academic umbrella body."